Treatment of gum loss in gum disease individuals using animal derived membrane along with patients blood derived substances
- Conditions
- Health Condition 1: K060- Gingival recession
- Registration Number
- CTRI/2024/05/067734
- Lead Sponsor
- kiran choudhary
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Systemically healthy subjects with an age range of 18-65 years.
2. Individuals diagnosed with recession defects in maxillary anteriors and premolars (Cairo’s RT1 , RT2 classes of recession)
3. Sites with minimum depth of recession =2mm.
4. Isolated or multiple adjoining recession involving =3 teeth.
1. Sites with probing pocket depth =4mm.
2.Teeth with mobility and/or associated with trauma from occlusion.
3. Sites with dental caries and prosthetic restorations.
4. Patients who exhibit unacceptable oral hygiene compliance
during/or after phase ? therapy.
5. Smokers.
6. Pregnant and lactating women.
7.Patient known allergic response with equine derived substances.
8.Patients with known platelet disorders or using any medication that are known to interfere with platelet function.
9. Patients with systemic conditions or disease influencing the course of periodontal disease and therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare the changes in the recession height from baseline to 6 months, within and between the study groupsTimepoint: Baseline and 6months
- Secondary Outcome Measures
Name Time Method 1. To assess and compare the percentage of complete root coverage (CRC%) achieved at 6 months between the research groups <br/ ><br>2.To assess and compare the patient perception regarding esthetics following the treatment modalities by using Visual Analogue Scale scores (VAS-E) <br/ ><br>Timepoint: 6months